Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: New Formulations of Propafenone to Treat Atrial Fibrillation [Phase 1, Phase 2]
Phase 1/2 trial update on new formulations of propafenone for atrial fibrillation; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study - [Phase 4]
Phase 4 clinical trial update for the Canadian Atrial Fibrillation Evaluation (CAFE) study evaluating atrial fibrillation treatment.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation [Phase 2]
Phase 2 pilot study evaluating edoxaban for resolving left atrial thrombosis in non-valvular atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI [Phase 4]
A Phase 4 trial comparing dual therapy with dabigatran and ticagrelor versus dabigatran and clopidogrel in ACS patients needing NOAC undergo…
-
FDA approval · 2021-04-21FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for propafenone hydrochloride (generic). The approval covers the treatment of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation [Phase 2]
Phase 2 trial update evaluating apixaban after anticoagulation-associated intracerebral hemorrhage in patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF) [Phase 4]
Phase 4 randomized trial comparing cryoballoon vs radiofrequency ablation for atrial fibrillation; non-inferiority design with completed sta…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Empagliflozin and Atrial Fibrillation Treatment [Phase 4]
A Phase 4 clinical trial update involving empagliflozin for atrial fibrillation treatment in patients with heart failure, obesity, and diabe…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study [NA]
Clinical trial on dual epicardial-endocardial ablation for persistent and longstanding persistent atrial fibrillation has completed with pos…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: GLORIA-AF Registry Program - Second and Third Phases
Registry update for GLORIA-AF program (Second and Third Phases) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD [Phase 4]
A Phase 4 trial update comparing dabigatran to warfarin in atrial fibrillation patients with type 2 diabetes and chronic kidney disease. The…
-
FDA approval · 2021-03-22FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approves Glenmark's diltiazem hydrochloride as an original ANDA; the product is a generic calcium channel blocker indicated for hyperten…
-
CLINICAL_TRIALS research · 2021-03-19Clinical Trial Update: Post-Market Surveillance With a Novel mHealth Platform
Post-market surveillance study evaluating a novel mobile health platform; completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation [Phase 3]
Phase 3 trial evaluating apixaban versus warfarin for reducing cognitive decline, silent cerebral infarcts, and cerebral microbleeds in atri…
-
CLINICAL_TRIALS research · 2021-03-16Clinical Trial Update: The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study [NA]
A completed clinical trial update study assessing how alcohol influences atrial tachyarrhythmias in atrial fibrillation patients; results po…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: The Correlation Between Sleep Quality and Atrial Fibrillation Undergoing High-flow Nasal Cannula Oxygen (HFNC) [Phase 4]
Phase 4 trial investigating the relationship between sleep quality and atrial fibrillation in patients with hypoxemia treated with high-flow…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: An Assessment of Dual Site Left Ventricular Endocardial Pacing [NA]
A completed clinical trial assessing dual site left ventricular endocardial pacing in patients with atrial fibrillation and ventricular tach…
-
FDA approval · 2021-03-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride by Mylan Pharmaceuticals, signaling approval of an updated or additional…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Colchicine in Atrial Fibrillation to Prevent Stroke [Phase 3]
Phase 3 trial update on colchicine for preventing stroke in patients with atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging [Phase 4]
Phase 4 trial update on isolation of pulmonary veins aided by magnetic resonance imaging for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation [Phase 4]
Phase 4 trial comparing amiodarone versus catheter ablation for prevention of recurrent symptomatic atrial fibrillation; study terminated.
-
FDA approval · 2021-02-04FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sotalol hydrochloride by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-02-04FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for Sotalol Hydrochloride.
-
FDA approval · 2021-01-27FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Sotalol Hydrochloride from Apotex Corp., approving changes to this generic product.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: The Deep Sedation for Ablation Study [Phase 4]
Phase 4 trial update on deep sedation protocols for atrial fibrillation ablation procedures.